Life and death in the granuloma: immunopathology of tuberculosis

被引:226
作者
Saunders, Bernadette M.
Britton, Warwick J.
机构
[1] Centenary Inst, Mycobacterial Res Programme, Newton, NSW 2042, Australia
[2] Univ Sydney, Cent Clin Sch, Discipline Med, Sydney, NSW 2006, Australia
关键词
granuloma; tuberculosis; reactivation; cytokines; chemokines;
D O I
10.1038/sj.icb.7100027
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
During tuberculosis (TB) infection, the granuloma provides the microenvironment in which antigen-specific T cells colocate with and activate infected macrophages to inhibit the growth of Mycobacterium tuberculosis. Although the granuloma is the site for mycobacterial killing, virulent mycobacteria have developed a variety of mechanisms to resist this macrophage-mediated killing. These surviving mycobacteria become dormant, however, if host cellular immunity or the signals maintaining granuloma structure wane, or if mycobacteria resume replication, leading to reactivation of TB. This balance of life and death applies not only to the mycobacterium but also to the host macrophages that may undergo apoptosis or necrosis, leading to the characteristic caseous necrosis within the granuloma, and the potential spread of TB infection. The immunological factors controlling the development and maintenance of the granuloma will be reviewed.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 136 条
  • [1] Algood HMS, 2004, J IMMUNOL, V173, P3287
  • [2] Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice
    Aly, S.
    Wagner, K.
    Keller, C.
    Malm, S.
    Malzan, A.
    Brandau, S.
    Bange, F-C
    Ehlers, S.
    [J]. JOURNAL OF PATHOLOGY, 2006, 210 (03) : 298 - 305
  • [3] IFN-γ-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection
    Azzurri, A
    Sow, OY
    Amedei, A
    Bah, B
    Diallo, S
    Peri, G
    Benagiano, M
    D'Elios, MM
    Mantovani, A
    Del Prete, G
    [J]. MICROBES AND INFECTION, 2005, 7 (01) : 1 - 8
  • [4] Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis
    Badewa, AP
    Quinton, LJ
    Shellito, JE
    Mason, CM
    [J]. TUBERCULOSIS, 2005, 85 (03) : 185 - 195
  • [5] TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
    Bafica, A
    Scanga, CA
    Feng, CG
    Leifer, C
    Cheever, A
    Sher, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) : 1715 - 1724
  • [6] Morphometric analysis of Th1 and Th2 cytokine expression in human pulmonary tuberculosis
    Bai, XY
    Wilson, SE
    Chmura, K
    Feldman, NE
    Chan, ED
    [J]. TUBERCULOSIS, 2004, 84 (06) : 375 - 385
  • [7] Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells
    Batten, Marcel
    Li, Ji
    Yi, Sothy
    Kljavin, Noelyn M.
    Danilenko, Dimitry M.
    Lucas, Sophie
    Lee, James
    de Sauvage, Frederic J.
    Ghilardi, Nico
    [J]. NATURE IMMUNOLOGY, 2006, 7 (09) : 929 - 936
  • [8] Bean AGD, 1999, J IMMUNOL, V162, P3504
  • [9] Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West Africa
    Campbell, SJ
    Sabeti, P
    Fielding, K
    Sillah, J
    Bah, B
    Gustafson, P
    Manneh, K
    Lisse, I
    Sirugo, G
    Bellamy, R
    Bennett, S
    Aaby, P
    McAdam, KPWJ
    Bah-Sow, O
    Lienhardt, C
    Hill, AVS
    [J]. IMMUNOGENETICS, 2003, 55 (07) : 502 - 507
  • [10] The human model: A genetic dissection of immunity to infection in natural conditions
    Casanova, JL
    Abel, L
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (01) : 55 - 66